| Mrs Savannah Grace Passmore, OTD | |
|
2918 Hawkins Dr, Searcy, AR 72143-4802 | |
| (501) 278-3438 | |
| Not Available |
| Full Name | Mrs Savannah Grace Passmore |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2918 Hawkins Dr, Searcy, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174246102 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT2022-022 (Arkansas) | Primary |
| Provider Name | Reaper Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1215973342 PECOS PAC ID: 5395637383 Enrollment ID: O20040325001112 |
News Archive
Researchers at The University of Texas M. D. Anderson Cancer Center have figured out a key molecular step by which a cancer cell can unhook itself from the mesh weave of other cancer cells in a tumor, and move away to a different part of the body - the process, known as metastasis, that makes cancer so dangerous.
The work of a team of scientists at Cold Spring Harbor Laboratory (CSHL) led by Professor Nicholas Tonks FRS, suggests a way to overcome one of the major technical obstacles preventing a leading therapeutic target for diabetes and obesity from being addressed successfully by novel drugs.
Janssen R&D Ireland today announced primary efficacy and safety results from two global Phase 3 studies demonstrating that use of the investigational protease inhibitor simeprevir (TMC435) led to sustained virologic response 12 weeks after the end of treatment (SVR12) in 80 and 81 percent, respectively, of treatment-naive genotype 1 chronic hepatitis C adult patients with compensated liver disease, including all stages of liver fibrosis, when administered once daily with pegylated interferon and ribavirin.
In the largest randomized controlled trial of treatment for high blood pressure ever conducted in sub-Saharan Africa, two frontline two-drug combinations that included the long-acting calcium channel blocker, amlodipine, were able to drive down blood pressure levels more than a third two-drug combination that did not include amlodipine, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Savannah Grace Passmore, OTD Po Box 43, Pleasant Plains, AR 72568-0043 Ph: (870) 612-7640 | Mrs Savannah Grace Passmore, OTD 2918 Hawkins Dr, Searcy, AR 72143-4802 Ph: (501) 278-3438 |
News Archive
Researchers at The University of Texas M. D. Anderson Cancer Center have figured out a key molecular step by which a cancer cell can unhook itself from the mesh weave of other cancer cells in a tumor, and move away to a different part of the body - the process, known as metastasis, that makes cancer so dangerous.
The work of a team of scientists at Cold Spring Harbor Laboratory (CSHL) led by Professor Nicholas Tonks FRS, suggests a way to overcome one of the major technical obstacles preventing a leading therapeutic target for diabetes and obesity from being addressed successfully by novel drugs.
Janssen R&D Ireland today announced primary efficacy and safety results from two global Phase 3 studies demonstrating that use of the investigational protease inhibitor simeprevir (TMC435) led to sustained virologic response 12 weeks after the end of treatment (SVR12) in 80 and 81 percent, respectively, of treatment-naive genotype 1 chronic hepatitis C adult patients with compensated liver disease, including all stages of liver fibrosis, when administered once daily with pegylated interferon and ribavirin.
In the largest randomized controlled trial of treatment for high blood pressure ever conducted in sub-Saharan Africa, two frontline two-drug combinations that included the long-acting calcium channel blocker, amlodipine, were able to drive down blood pressure levels more than a third two-drug combination that did not include amlodipine, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
› Verified 2 days ago
Sarah Beth Lemay, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 502 E Race Ave, Searcy, AR 72143 Phone: 501-268-3400 | |
Melissa A Tharp, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 220 Gravel Hill Rd, Searcy, AR 72143 Phone: 501-230-8964 | |
Audrey Regan Robertson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 502 E Race Ave, Searcy, AR 72143 Phone: 870-932-3600 | |
Mrs. Jill Dovie Hall, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2501 E Moore Ave, Searcy, AR 72143 Phone: 501-268-5001 Fax: 501-268-5443 | |
Tillie Stracener Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 701 Valley Ct, Searcy, AR 72143 Phone: 501-281-6677 | |
Megan Graham, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2501 E Moore Ave, Searcy, AR 72143 Phone: 501-268-5001 Fax: 501-268-5443 |